Case Study of Custom Buffer for Drug Discovery
Solving the challenges of buffer preparation in screening!
In the drug discovery industry, the quality and stability of buffers are crucial factors that influence the success of experiments during screening. Particularly, as the demand for increased efficiency and accuracy in screening grows, it is essential to shorten buffer preparation time, ensure uniform quality, and provide flexible responses. Our custom buffers address these challenges and contribute to the efficiency of screening. 【Use Cases】 - Screening experiments - Cell culture - Protein purification 【Benefits of Implementation】 - Reduction in buffer preparation time - Stable supply of high-quality buffers - Flexible responses tailored to experimental scale - Support for long-term stability testing
basic information
**Features** - Established a stable supply system in collaboration with single-use bag manufacturers - Deliver products in accordance with the customer's usage timing - Support long-term stability testing **Our Strengths** We are a contract manufacturing company for liquid media and buffers that complies with GMP standards. By combining high-quality amino acid-based media raw materials from Ajinomoto Co., Inc. with advanced production technology from Cojin Bio Co., Ltd., we provide custom buffers tailored to our customers' needs.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Buffer for Cultivation and Purification *For more details, please refer to the related links or feel free to contact us.
catalog（2）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.